These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21420205)

  • 1. Antineoplastic activity of the thiazolo[5,4-b]quinoline derivative D3CLP in K-562 cells is mediated through effector caspases activation.
    González-Sánchez I; Solano JD; Loza-Mejía MA; Olvera-Vázquez S; Rodríguez-Sotres R; Morán J; Lira-Rocha A; Cerbón MA
    Eur J Med Chem; 2011 Jun; 46(6):2102-8. PubMed ID: 21420205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
    González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
    Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic Profiling Reveals the Induction of UPR in Addition to DNA Damage Response in HeLa Cells Treated With the Thiazolo[5,4-b]Quinoline Derivative D3ClP.
    Páez-Franco JC; González-Sánchez I; Gutiérrez-Nájera NA; Valencia-Turcotte LG; Lira-Rocha A; Cerbón MA; Rodríguez-Sotres R
    J Cell Biochem; 2017 May; 118(5):1164-1173. PubMed ID: 27684057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of new substituted 3-(5-imidazo[2,1-b]thiazolylmethylene)-2-indolinones and 3-(5-imidazo[2,1-b]thiadiazolylmethylene)-2-indolinones: selectivity against colon tumor cells and effect on cell cycle-related events.
    Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Calonghi N; Cappadone C; Voltattorni M; Zini M; Stefanelli C; Masotti L; Shoemaker RH
    J Med Chem; 2008 Dec; 51(23):7508-13. PubMed ID: 19006285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential antitumor agents. 37. Synthesis and antitumor activity of guanylhydrazones from imidazo[2,1-b]thiazoles and from the new heterocyclic system thiazolo[2',3':2,3]imidazo[4,5-c]quinoline.
    Andreani A; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Lenaz G; Fato R; Bergamini C; Farruggia G
    J Med Chem; 2005 Apr; 48(8):3085-9. PubMed ID: 15828848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor evaluation of new thiazolo[5,4-b]quinoline derivatives.
    Alvarez-Ibarra C; Fernández-Granda R; Quiroga ML; Carbonell A; Cárdenas F; Giralt E
    J Med Chem; 1997 Feb; 40(5):668-76. PubMed ID: 9057853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bis(2-hydroxybenzylidene)acetone, a potent inducer of the phase 2 response, causes apoptosis in mouse leukemia cells through a p53-independent, caspase-mediated pathway.
    Dinkova-Kostova AT; Cory AH; Bozak RE; Hicks RJ; Cory JG
    Cancer Lett; 2007 Jan; 245(1-2):341-9. PubMed ID: 16517063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro biological evaluation of new polyamine conjugates as potential anticancer drugs.
    Szumilak M; Szulawska-Mroczek A; Koprowska K; Stasiak M; Lewgowd W; Stanczak A; Czyz M
    Eur J Med Chem; 2010 Dec; 45(12):5744-51. PubMed ID: 20974504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells.
    Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY
    Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals.
    Rodríguez-Loaiza P; Quintero A; Rodríguez-Sotres R; Solano JD; Lira-Rocha A
    Eur J Med Chem; 2004 Jan; 39(1):5-10. PubMed ID: 14987829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel synthesized 2-(3-(methylamino)phenyl)-6-(pyrrolidin-1-yl)quinolin-4-one (Smh-3) compound induces G2/M phase arrest and mitochondrial-dependent apoptotic cell death through inhibition of CDK1 and AKT activity in HL-60 human leukemia cells.
    Huang SM; Yang JS; Tsai SC; Chen MH; Hsu MH; Lin HY; Chou LC; Chinag JH; Lee KH; Huang LJ; Kuo SC
    Int J Oncol; 2011 May; 38(5):1357-64. PubMed ID: 21344160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-(3-Phenoxybenzyl)amino-β-carboline: a novel antitumor drug targeting α-tubulin.
    Ikeda R; Kurosawa M; Okabayashi T; Takei A; Yoshiwara M; Kumakura T; Sakai N; Funatsu O; Morita A; Ikekita M; Nakaike Y; Konakahara T
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4784-7. PubMed ID: 21752645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiproliferative effects of some novel synthetic solanidine analogs on HL-60 human leukemia cells in vitro.
    Minorics R; Szekeres T; Krupitza G; Saiko P; Giessrigl B; Wölfling J; Frank E; Zupkó I
    Steroids; 2011 Jan; 76(1-2):156-62. PubMed ID: 20974162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late activation of apoptotic pathways plays a negligible role in mediating the cytotoxic effects of discodermolide and epothilone B in non-small cell lung cancer cells.
    Bröker LE; Huisman C; Ferreira CG; Rodriguez JA; Kruyt FA; Giaccone G
    Cancer Res; 2002 Jul; 62(14):4081-8. PubMed ID: 12124345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro evaluation of the anticancer activity of novel fluorinated thiazolo[4, 5-d]pyrimidines.
    Fahmy HT; Rostom SA; Saudi MN; Zjawiony JK; Robins DJ
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):216-25. PubMed ID: 12916055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity, apoptosis induction, and mitotic arrest by a novel podophyllotoxin glucoside, 4DPG, in tumor cells.
    Qi YL; Liao F; Zhao CQ; Lin YD; Zuo MX
    Acta Pharmacol Sin; 2005 Aug; 26(8):1000-8. PubMed ID: 16038635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective induction of G2/M arrest and apoptosis in HL-60 by a potent anticancer agent, HMJ-38.
    Yang JS; Hour MJ; Kuo SC; Huang LJ; Lee MR
    Anticancer Res; 2004; 24(3a):1769-78. PubMed ID: 15274354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of new symmetrical derivatives as cytotoxic agents and apoptosis inducers.
    Sanmartín C; Echeverría M; Mendívil B; Cordeu L; Cubedo E; García-Foncillas J; Font M; Palop JA
    Bioorg Med Chem; 2005 Mar; 13(6):2031-44. PubMed ID: 15727857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.